We are live on ! Find out more
HAIAU

Healthcare AI Acquisition Corp. Unit

Delisted

HAIAU was delisted on the 6th of December, 2024.

9 hedge funds and large institutions have $5.19M invested in Healthcare AI Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% less funds holding

Funds holding: 139 (-4)

74% less capital invested

Capital invested by funds: $20M → $5.19M (-$14.8M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change

HAIAU Hedge Fund Activity: Q4 2022 in Review

9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Healthcare AI Acquisition Corp. Unit (HAIAU) for Q4 2022, worth a combined $5.19M — down 74% from $20M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of HAIAU and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.

The largest seller was Calamos Advisors, exiting entirely with an estimated $10.1M sold.

  • 9 institutional investors held Healthcare AI Acquisition Corp. Unit (HAIAU) as of Q4 2022, down from 13 in Q3 2022.
  • Funds reported $5.19M of Healthcare AI Acquisition Corp. Unit stock for Q4 2022, down 74% quarter-over-quarter.
  • 1 fund opened new Healthcare AI Acquisition Corp. Unit positions in Q4 2022 and 5 closed out, a net change of -4 holders.
  • The largest Healthcare AI Acquisition Corp. Unit seller in Q4 2022 was Calamos Advisors, an estimated $10.1M sold.

Based on aggregated 13F filings for Q4 2022.